| # | Title | Journal | Year | Citations |
|---|
| 1 | Designing of Novel Carbonic Anhydrase Inhibitors and Activators | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 138 |
| 2 | The Adipose Tissue as a Source of Vasoactive Factors | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 92 |
| 3 | Cardiovascular Alterations After Spinal Cord Injury: An Overview | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 74 |
| 4 | Smoking, Estradiol Metabolism and Hormone Replacement Therapy | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 55 |
| 5 | Blockers of the Kv1.5 Channel for the Treatment of Atrial Arrhythmias [1] | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 55 |
| 6 | Cardiovascular Effects of the Phytoestrogen Genistein | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 54 |
| 7 | The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 48 |
| 8 | Risk Stratification of Dyslipidemia: Insights from the Framingham Study | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 48 |
| 9 | New Insights into the Intracellular Mechanisms by Which PGI2 Analogues Elicit Vascular Relaxation: Cyclic AMP-Independent, Gs-Protein Mediated-Activation of MaxiK Channel | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 46 |
| 10 | Natriuretic Peptide Family: New Aspects | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 45 |
| 11 | Recent Progress in Signal Transduction Research of the Angiotensin II Type-1 Receptor: Protein Kinases, Vascular Dysfunction and Structural Requirement | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 43 |
| 12 | Angiotensin-(1-7): Blood, Heart, and Blood Vessels | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 43 |
| 13 | Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 40 |
| 14 | Capsaicin Sensitive-Sensory Nerves and Blood Pressure Regulation | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 37 |
| 15 | Cardiac Adrenomedullin: Its Role in Cardiac Hypertrophy and Heart Failure | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 37 |
| 16 | Vasoprotective Actions of the Atrial Natriuretic Peptide | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 36 |
| 17 | Role of Calmodulin in Platelet Receptor Function | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 36 |
| 18 | Discovery of Potent Peptide-Mimetic Antagonists for the Human Thrombin Receptor, Protease-Activated Receptor-1 (PAR-1) | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 35 |
| 19 | Discovery and Pre-clinical Development of Antithrombotics from Hematophagous Invertebrates | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 35 |
| 20 | Thrombocytopenia in HIV Disease: Clinical Relevance, Physiopathology and Management | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 35 |
| 21 | Recent Advances in Marine Algal Anticoagulants | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 33 |
| 22 | Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 31 |
| 23 | Anti-Inflammatory and Anti-Apoptotic Effects of Levosimendan in Decompensated Heart Failure: A Novel Mechanism of Drug-Induced Improvement in Contractile Performance of the Failing Heart | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 30 |
| 24 | Physicochemical Determinants for Drug Induced Blockade of HERG Potassium Channels: Effect of Charge and Charge Shielding | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 29 |
| 25 | Snake Venom Metalloproteinase Containing a Disintegrin-like Domain, its Structure-activity Relationships at Interacting with Integrins | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 28 |
| 26 | New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 27 |
| 27 | Designing of novel carbonic anhydrase inhibitors and activators | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 27 |
| 28 | Catalytic Features, Regulation and Function of Myocardial Phospholipase A2 | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 26 |
| 29 | Structure-activity Relationships of Snake Toxins Targeting Platelet Receptors, Glycoprotein Ib-IX-V and Glycoprotein VI | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 25 |
| 30 | The Multifunctional Protein C System | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 25 |
| 31 | Fibrinolysis at the Fluid-Solid Interface of Thrombi | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 25 |
| 32 | Dopamine Receptor and Hypertension | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 24 |
| 33 | Urocortins: Putative Role in Cardiovascular Disease | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 23 |
| 34 | Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 22 |
| 35 | Combination of Phytosterols and Omega-3 Fatty Acids: A Potential Strategy to Promote Cardiovascular Health | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 21 |
| 36 | Prostacyclin Synthase Gene: Genetic Polymorphisms and Prevention of Some Cardiovascular Diseases | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 20 |
| 37 | α2-Antiplasmin: Potential Therapeutic Roles in Fibrin Survival and Removal | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 20 |
| 38 | Understanding the Mechanism and Prevention of Arterial Occlusive Thrombus Formation by Anti-Platelet Agents | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 20 |
| 39 | L-Arginine Transport in Disease | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 20 |
| 40 | Aspirin and Clopidogrel: A Sweeping Combination in Cardiology | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 19 |
| 41 | Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 19 |
| 42 | Blockers of the Slowly Delayed Rectifier Potassium IKs Channel: Potential Antiarrhythmic Agents | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 19 |
| 43 | Influence of Impaired Liver Methionine Metabolism on the Development of Vascular Disease and Inflammation | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 18 |
| 44 | IKr Channel Blockers: Novel Antiarrhythmic Agents | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 18 |
| 45 | Diadenosine Polyphosphates: Postulated Mechanisms Mediating the Cardiac Effects | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2003 | 18 |
| 46 | The Pharmacologic Approach to the Prevention of Preeclampsia: From Antiplatelet, Antithrombosis and Antioxidant Therapy to Anticonvulsants | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 17 |
| 47 | Pleiotropic Effects of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors: Candidate Mechanisms for Anti-Lipid Deposition in Blood Vessels | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 17 |
| 48 | Salutary Properties of YC-1 in the Cardiovascular and Hematological Systems | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2004 | 17 |
| 49 | Left Ventricular Hypertrophy and Angiotensin II Receptor Blocking Agents | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 16 |
| 50 | Molecular Predictors of Drug-induced Prolongation of the QT Interval | Current Medicinal Chemistry Cardiovascular and Hematological Agents | 2005 | 16 |
